The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases
|
---|---|
Published in |
Frontiers in oncology, October 2021
|
DOI | 10.3389/fonc.2021.722331 |
Pubmed ID | |
Authors |
Ran Yu, Guihua Jin, Manabu Fujimoto |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Korea, Republic of | 1 | 33% |
Switzerland | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 27 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Doctoral Student | 3 | 11% |
Student > Bachelor | 2 | 7% |
Student > Master | 2 | 7% |
Professor > Associate Professor | 2 | 7% |
Student > Ph. D. Student | 1 | 4% |
Other | 3 | 11% |
Unknown | 14 | 52% |
Readers by discipline | Count | As % |
---|---|---|
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 15% |
Medicine and Dentistry | 4 | 15% |
Business, Management and Accounting | 1 | 4% |
Biochemistry, Genetics and Molecular Biology | 1 | 4% |
Agricultural and Biological Sciences | 1 | 4% |
Other | 1 | 4% |
Unknown | 15 | 56% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2024.
All research outputs
#7,749,226
of 26,476,278 outputs
Outputs from Frontiers in oncology
#2,791
of 23,227 outputs
Outputs of similar age
#144,279
of 443,062 outputs
Outputs of similar age from Frontiers in oncology
#141
of 1,469 outputs
Altmetric has tracked 26,476,278 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 23,227 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,062 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 1,469 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.